Atlas Trials

HER2 Overexpressing Gastric Carcinoma

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch HER2 Overexpressing Gastric Carcinoma

RecordFirmDate
A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression (NCT04714190)RemeGen Co., Ltd.2021-03-24
A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer Subjects With the Overexpression of HER2 (NCT03556345)RemeGen Co., Ltd.2018-07-10

Track HER2 Overexpressing Gastric Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.